Latest News about PYPD
Recent news which mentions PYPD
61 Stocks Moving In Tuesday's Mid-Day Session
December 22, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger
November 20, 2020
From Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
Earnings Scheduled For November 11, 2020
November 11, 2020
From Benzinga
56 Biggest Movers From Yesterday
October 16, 2020
From Benzinga
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
October 15, 2020
From Benzinga
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
October 08, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Moderna Japanese Vaccine Deal Talk, Lipocine FDA Decision, Liver Congress Presentations
August 28, 2020
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For August 19, 2020
August 19, 2020
From Benzinga
The Daily Biotech Pulse: Poseida's Phase 1 Study Placed On Clinical Hold, Orphan Drug Designation For Krystal Biotech, Tiziana's Patent Award
August 18, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 10, 2020
August 10, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 05, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For July 21, 2020
July 21, 2020
From Benzinga
The Week Ahead In Biotech: Jazz Awaits FDA Nod For Sleep Disorder Drug, Earnings Trickle In, ACell IPO
July 19, 2020
From Benzinga
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
July 10, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.